文献速递心境障碍焦虑、强迫与应激相关障碍

英国生物银行中抗抑郁药更换模式的理解

Understanding antidepressant change patterns in the UK Biobank.
PubMed 文献 · Br J Psychiatry · 2026-07-17

基于英国生物银行初级保健记录,研究分析了82 633名至少被处方一种抗抑郁药个体的换药与停药模式,比较抑郁与非抑郁适应症差异,并评估临床与遗传因素。结果显示抑郁组更可能长期用药,换药与停药与精神及躯体疾病相关,遗传分析发现两个与SSRI早期停药相关的新变异。

要点

  • 抑郁组较非抑郁组更可能长期服用抗抑郁药并追随随时间变化的偏好药物。
  • 复发抑郁和焦虑与抑郁组早期及晚期停药风险升高相关。
  • 遗传分析发现两个与SSRI早期停药相关的新变异,抑郁与ADHD多基因评分对治疗结局有显著预测价值。

核心结论

  • 初级保健记录中的抗抑郁药更换模式可被系统刻画。
  • 整合临床与遗传数据有助于理解抗抑郁药治疗结局相关因素。

研究设计与样本

  • 使用英国生物银行初级保健记录,共82 633名至少被处方1种抗抑郁药的个体。
  • 其中28 332名有至少1次初级保健抑郁诊断者为抑郁组,24 543名无抑郁证据者为非抑郁组。
  • 结局包括抗抑郁药更换次数及因副作用或应答不足导致的停药,并进行遗传力估计、遗传相关和多基因评分关联分析。

主要发现

  • 抑郁组最常处方西酞普兰和氟西汀,非抑郁适应症以阿米替林为主。
  • 抑郁组比非抑郁组更可能长期用药并追随随时间变化的偏好抗抑郁药。
  • 抑郁组中复发抑郁与早期停药(OR=1.96)和晚期停药(OR=2.63)相关,焦虑与早期停药(OR=1.37)和晚期停药(OR=1.99)相关。
  • 非抑郁组中疼痛相关疾病与换药和停药相关。
  • 遗传分析发现两个与SSRI早期停药相关的新变异,换药次数与焦虑和抑郁的遗传相关为rg=0.81-0.83。

关键数值与推荐

  • 抑郁组复发抑郁:早期停药OR=1.96,晚期停药OR=2.63。
  • 抑郁组焦虑:早期停药OR=1.37,晚期停药OR=1.99。
  • 换药次数与焦虑和抑郁的遗传相关rg=0.81-0.83。
  • 抑郁和ADHD多基因评分对治疗结局有显著预测价值。

临床怎么用

  • 临床可关注抑郁共病焦虑或复发抑郁患者,其停药风险较高。
  • 非抑郁适应症处方抗抑郁药时需注意疼痛相关疾病与换药停药的关系。
  • 遗传信息可能辅助识别SSRI早期停药风险,但需进一步验证。

局限性

  • 研究基于英国生物银行初级保健记录,可能受记录完整性和人群代表性限制。
  • 原文未报告遗传分析的样本量、阈值或P值等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antidepressants are the most frequently prescribed medications in psychiatry. Medical records of thousands of individuals provide a valuable opportunity to explore prescribing patterns and identify factors that influence treatment outcomes. AIMS: To investigate antidepressant change patterns in depression and non-depression indications and assess clinical and genetic factors associated with outcomes of antidepressant treatment. METHODS: Using primary care records from the UK Biobank, we examined outcomes including number of antidepressant changes and discontinuation due to either side-effects or inadequate response. Genetic analyses including heritability estimation, genetic correlation and polygenic score association were performed. RESULTS: A total of 82 633 individuals were prescribed at least 1 antidepressant. Of these, 28 332 individuals with at least 1 primary care depression diagnosis were classified as the depression group, and 24 543 individuals without evidence of depression were classified as the non-depression group. Citalopram and fluoxetine were the most prescribed antidepressants for depression, whereas amitriptyline dominated prescriptions for non-depression indications. Individuals with depression were more likely to stay on antidepressants longer than those without depression and to follow preferred antidepressants that changed over time. Antidepressant changes and discontinuation were associated with a range of psychiatric and somatic conditions, including recurrent depression (early discontinuation: odds ratio = 1.96; late discontinuation: odds ratio = 2.63) and anxiety (early discontinuation: odds ratio = 1.37; late discontinuation: odds ratio = 1.99) in the depression group, and pain-related conditions in the non-depression group. Genetic analyses identified two novel variants associated with early discontinuation of selective serotonin reuptake inhibitors. Notable genetic overlap was shown between these outcomes and multiple psychiatric and physical traits, including the number of antidepressant changes with anxiety and depression (rg = 0.81-0.83), and polygenic scores for depression and attention-deficit hyperactivity disorder showed significant predictive value with respect to treatment outcomes. CONCLUSIONS: These findings characterise antidepressant change patterns in primary care records and highlight the potential value of integrating clinical and genetic data to better understand factors associated with treatment outcomes.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Li D, Lo CWH, Lewis CM, et al. Understanding antidepressant change patterns in the UK Biobank. Br J Psychiatry. 2026. PMID: 42464625. doi:10.1192/bjp.2026.10719

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。